324 related articles for article (PubMed ID: 34624173)
21. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
[TBL] [Abstract][Full Text] [Related]
22. Differentiated service delivery for people using second-line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu-Natal, South Africa.
Lewis L; Sookrajh Y; Gate K; Khubone T; Maraj M; Mkhize S; Hermans LE; Ngobese H; Garrett N; Dorward J
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25802. PubMed ID: 34713545
[TBL] [Abstract][Full Text] [Related]
23. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
[TBL] [Abstract][Full Text] [Related]
24. Enhancing linkage to HIV care in the "Universal Test and Treat" era: Barriers and enablers to HIV care among adults in a high HIV burdened district in KwaZulu-Natal, South Africa.
Nicol E; Jama NA; Mehlomakulu V; Hlongwa M; Pass D; Basera W; Bradshaw D
BMC Public Health; 2023 Sep; 23(1):1756. PubMed ID: 37689667
[TBL] [Abstract][Full Text] [Related]
25. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.
Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Orne-Gliemann J; Pillay D; Dabis F;
J Int AIDS Soc; 2019 Oct; 22(10):e25402. PubMed ID: 31637821
[TBL] [Abstract][Full Text] [Related]
26. Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study.
Barnabas RV; van Heerden A; McConnell M; Szpiro AA; Krows ML; Schaafsma TT; Ngubane T; Nxele RB; Joseph P; Baeten JM; Celum CL; van Rooyen H
J Int AIDS Soc; 2020 Jun; 23 Suppl 2(Suppl 2):e25519. PubMed ID: 32589342
[TBL] [Abstract][Full Text] [Related]
27. Understanding how community antiretroviral delivery influences engagement in HIV care: a qualitative assessment of the Centralised Chronic Medication Dispensing and Distribution programme in South Africa.
Dorward J; Msimango L; Gibbs A; Shozi H; Tonkin-Crine S; Hayward G; Butler CC; Ngobese H; Drain PK; Garrett N
BMJ Open; 2020 May; 10(5):e035412. PubMed ID: 32414827
[TBL] [Abstract][Full Text] [Related]
28. Why do patients interrupt and return to antiretroviral therapy? Retention in HIV care from the patient's perspective in Johannesburg, South Africa.
Bisnauth MA; Davies N; Monareng S; Buthelezi F; Struthers H; McIntyre J; Rees K
PLoS One; 2021; 16(9):e0256540. PubMed ID: 34473742
[TBL] [Abstract][Full Text] [Related]
29. Undisclosed Antiretroviral Therapy Use at Primary Health Care Clinics in Rural KwaZulu Natal South Africa: A DO-ART Trial Sub-study.
Sithole N; Gunda R; Koole O; Krows M; Schaafsma T; Moshabela M; Siedner MJ; Celum C; Barnabas RV
AIDS Behav; 2021 Nov; 25(11):3695-3703. PubMed ID: 34097208
[TBL] [Abstract][Full Text] [Related]
30. Community-based differentiated service delivery models incorporating multi-month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits: a pooled analysis of two cluster-randomized trials in southern Africa.
Fatti G; Ngorima-Mabhena N; Tiam A; Tukei BB; Kasu T; Muzenda T; Maile K; Lombard C; Chasela C; Grimwood A
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25819. PubMed ID: 34713614
[TBL] [Abstract][Full Text] [Related]
31. Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.
Msimango L; Gibbs A; Shozi H; Ngobese H; Humphries H; Drain PK; Garrett N; Dorward J
BMC Health Serv Res; 2020 Nov; 20(1):1081. PubMed ID: 33239012
[TBL] [Abstract][Full Text] [Related]
32. Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study.
Barnabas RV; van Rooyen H; Tumwesigye E; Murnane PM; Baeten JM; Humphries H; Turyamureeba B; Joseph P; Krows M; Hughes JP; Celum C
Lancet HIV; 2014 Nov; 1(2):e68-e76. PubMed ID: 25601912
[TBL] [Abstract][Full Text] [Related]
33. Factors that influence the satisfaction of people living with HIV with differentiated antiretroviral therapy delivery models in east Central Uganda: a cross-sectional study.
Baleeta K; Muhwezi A; Tumwesigye N; Kintu BN; Riese S; Byonanebye D; Mbonye M; Mwehire D; Iriso R; Ayebazibwe B; Bailey L; Lopez D; McGough L; Etukoit M; Nantamu D; Nakitende L; Tibengana B; Wasswa J
BMC Health Serv Res; 2023 Feb; 23(1):127. PubMed ID: 36750840
[TBL] [Abstract][Full Text] [Related]
34. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
35. Perceptions and factors associated with the uptake of the community client-led antiretroviral therapy delivery model (CCLAD) at a large urban clinic in Uganda: a mixed methods study.
Walusaga HAG; Atuyambe LM; Muddu M; Mpirirwe R; Nangendo J; Kalibbala D; Semitala FC; Katahoire AR
BMC Health Serv Res; 2023 Oct; 23(1):1165. PubMed ID: 37885014
[TBL] [Abstract][Full Text] [Related]
36. Depression and anxiety as barriers to art initiation, retention in care, and treatment outcomes in KwaZulu-Natal, South Africa.
Truong M; Rane MS; Govere S; Galagan SR; Moosa MY; Stoep AV; Celum C; Drain PK
EClinicalMedicine; 2021 Jan; 31():100621. PubMed ID: 33490927
[TBL] [Abstract][Full Text] [Related]
37. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis.
Brown LB; Getahun M; Ayieko J; Kwarisiima D; Owaraganise A; Atukunda M; Olilo W; Clark T; Bukusi EA; Cohen CR; Kamya MR; Petersen ML; Charlebois ED; Havlir DV; Camlin CS
PLoS One; 2019; 14(1):e0210126. PubMed ID: 30673744
[TBL] [Abstract][Full Text] [Related]
38. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
[TBL] [Abstract][Full Text] [Related]
39. Differentiated service delivery: a qualitative study of people living with HIV and accessing care in a tertiary facility in Ghana.
Adjetey V; Obiri-Yeboah D; Dornoo B
BMC Health Serv Res; 2019 Feb; 19(1):95. PubMed ID: 30717715
[TBL] [Abstract][Full Text] [Related]
40. Healthcare provider perceptions on the implementation of the universal test-and-treat policy in South Africa: a qualitative inquiry.
Nicol E; Mehlomakulu V; Jama NA; Hlongwa M; Basera W; Pass D; Bradshaw D
BMC Health Serv Res; 2023 Mar; 23(1):293. PubMed ID: 36978086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
